MedTrace Logo

Clinical Assessment and Psychosocial Impact of Psoriasis

NCT01964443 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 719

Last updated 2015-12-15

No results posted yet for this study

Summary

The purpose of this study is to explore the impact of plaque psoriasis on the different dimensions of patient life including psychological disorders, different types of addictions, and their consequences on health-related quality of life and socioeconomic parameters at baseline (cross-sectional part) and during the initial years of the psoriasis disease (longitudinal part).

Conditions

Sponsors & Collaborators

  • Janssen Pharmaceutica N.V., Belgium

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Austria
  • Belgium
  • France
  • Greece
  • Ireland
  • Israel
  • Netherlands
  • Norway
  • Russia
  • South Africa
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964443 on ClinicalTrials.gov